Literature DB >> 32097115

Prostate Cancer and Asbestos: A Systematic Review and Meta-Analysis.

Frédéric Dutheil1,2, Laetitia Zaragoza-Civale3, Bruno Pereira4, Martial Mermillod5,6, Julien S Baker7, Jeannot Schmidt8, Fares Moustafa9, Valentin Navel10.   

Abstract

INTRODUCTION: Asbestos-related diseases and cancers represent a major public health concern.
OBJECTIVE: To conduct a systematic review and meta-analysis to demonstrate that asbestos exposure increases the risk of prostate cancer.
METHODS: The PubMed, Cochrane Library, Embase, and ScienceDirect databases were searched using the keywords (prostate cancer OR prostatic neoplasm) AND (asbestos* OR crocidolite* OR chrysotile* OR amphibole* OR amosite*). To be included, articles needed to describe our primary outcome: Risk of prostate cancer after any asbestos exposure.
RESULTS: We included 33 studies with 15,687 cases of prostate cancer among 723,566 individuals. Asbestos exposure increased the risk of prostate cancer (effect size = 1.10, 95% confidence interval [CI] = 1.05-1.15). When we considered mode of absorption, respiratory inhalation increased the risk of prostate cancer (1.10, 95% CI = 1.05-1.14). Both environmental and occupational exposure increased the risk of prostate cancer (1.25, 95% CI = 1.01-1.48; and 1.07, 1.04-1.10, respectively). For type of fibers, the amosite group had an increased risk of prostate cancer (1.12, 95% CI = 1.05-1.19), and there were no significant results for the chrysotile/crocidolite group. The risk was higher in Europe (1.12, 95% CI = 1.05-1.19), without significant results in other continents. DISCUSSION: Asbestos exposure seems to increase prostate cancer risk. The main mechanism of absorption was respiratory. Both environmental and occupational asbestos exposure were linked to increased risk of prostate cancer.
CONCLUSION: Patients who were exposed to asbestos should possibly be encouraged to complete more frequent prostate cancer screening.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32097115      PMCID: PMC7039423          DOI: 10.7812/TPP/19.086

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  109 in total

1.  A simple method for converting an odds ratio to effect size for use in meta-analysis.

Authors:  S Chinn
Journal:  Stat Med       Date:  2000-11-30       Impact factor: 2.373

2.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

3.  Impact of chemical exposure on cancer mortality in a French cohort of uranium processing workers.

Authors:  Sergey Zhivin; Dominique Laurier; Sylvaine Caër-Lorho; Alain Acker; Irina Guseva Canu
Journal:  Am J Ind Med       Date:  2013-09-06       Impact factor: 2.214

Review 4.  The global spread of asbestos.

Authors:  Arthur L Frank; T K Joshi
Journal:  Ann Glob Health       Date:  2014-11-25       Impact factor: 2.462

5.  Asbestos: Modern Insights for Toxicology in the Era of Engineered Nanomaterials.

Authors:  Emanuela Felley-Bosco; Marion MacFarlane
Journal:  Chem Res Toxicol       Date:  2018-09-12       Impact factor: 3.739

6.  Incidence of cancer among the participants of the Finnish Asbestos Screening Campaign.

Authors:  Kari Koskinen; Eero Pukkala; Kari Reijula; Antti Karjalainen
Journal:  Scand J Work Environ Health       Date:  2003-02       Impact factor: 5.024

7.  Uses and misuses of the STROBE statement: bibliographic study.

Authors:  Bruno R da Costa; Myriam Cevallos; Douglas G Altman; Anne W S Rutjes; Matthias Egger
Journal:  BMJ Open       Date:  2011-02-26       Impact factor: 2.692

Review 8.  Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis.

Authors:  Cédric Benoist d'Azy; Bruno Pereira; Frédéric Chiambaretta; Frédéric Dutheil
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

9.  Accumulation of ingested asbestos fibers in rat tissues over time.

Authors:  K Patel-Mandlik; J Millette
Journal:  Environ Health Perspect       Date:  1983-11       Impact factor: 9.031

10.  Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium.

Authors:  José Manuel Ordóñez-Mena; Ben Schöttker; Ute Mons; Mazda Jenab; Heinz Freisling; Bas Bueno-de-Mesquita; Mark G O'Doherty; Angela Scott; Frank Kee; Bruno H Stricker; Albert Hofman; Catherine E de Keyser; Rikje Ruiter; Stefan Söderberg; Pekka Jousilahti; Kari Kuulasmaa; Neal D Freedman; Tom Wilsgaard; Lisette Cpgm de Groot; Ellen Kampman; Niclas Håkansson; Nicola Orsini; Alicja Wolk; Lena Maria Nilsson; Anne Tjønneland; Andrzej Pająk; Sofia Malyutina; Růžena Kubínová; Abdonas Tamosiunas; Martin Bobak; Michail Katsoulis; Philippos Orfanos; Paolo Boffetta; Antonia Trichopoulou; Hermann Brenner
Journal:  BMC Med       Date:  2016-04-05       Impact factor: 8.775

View more
  4 in total

1.  An Innovative Filtering System for the Handling of Asbestos-Based Products: Improvement of Safety and Quality of Work in Analysis Laboratories.

Authors:  Oriana Motta; Concetta Pironti; Marta Venier; Antonio Proto
Journal:  Toxics       Date:  2022-05-25

2.  Global DNA methylation of WTC prostate cancer tissues show signature differences compared to non-exposed cases.

Authors:  Haocheng Yu; Stephanie Tuminello; Naomi Alpert; Maaike van Gerwen; Seungyeul Yoo; David J Mulholland; Stuart A Aaronson; Michael Donovan; William K Oh; Yixuan Gong; Li Wang; Jun Zhu; Emanuela Taioli
Journal:  Carcinogenesis       Date:  2022-06-27       Impact factor: 4.741

3.  Re: Dutheil et al. Prostate Cancer and Asbestos: A Systematic Review and Meta-Analysis.

Authors:  Paolo Boffetta; Nicolò Franco; Attilia Gullino; Enrico Pira
Journal:  Perm J       Date:  2021-01

4.  Mesothelioma and Colorectal Cancer: Report of Four Cases with Synchronous and Metachronous Presentation.

Authors:  Gabriella Serio; Federica Pezzuto; Francesco Fortarezza; Andrea Marzullo; Maria Celeste Delfino; Antonio d'Amati; Daniele Egidio Romano; Sonia Maniglio; Concetta Caporusso; Teresa Lettini; Domenica Cavone; Luigi Vimercati
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.